Does Low Disease Activity at Six Months Predict Remission at 12 Months in Rheumatoid Arthritis Patients Treated with Biologics in a Real-World Setting?

被引：0
|
作者：
Baer, Philip
Bensen, William [1 ,2 ]
Chow, Andrew [3 ]
Faraawi, Rafat [4 ]
Choquette, Denis [5 ]
Fortin, Isabelle [6 ]
Kelsall, John [7 ,8 ]
Sholter, Dalton [9 ]
Rampakakis, Emmanouil [10 ,11 ]
Sampalis, John [10 ,11 ]
Nantel, Francois [12 ]
Shawi, May [13 ]
Lehman, Allen [13 ]
Otawa, Susan [13 ]
机构：
[1] St Josephs Hosp, Hamilton, ON, Canada
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] McMaster Univ, Univ Toronto, Mississauga, ON, Canada
[4] KW Musculoskeletal Res Inc, Kitchener, ON, Canada
[5] Inst Rhumatol Montreal, Montreal, PQ, Canada
[6] Ctr Sante & Serv Sociaux Rimousk, Rimouski, PQ, Canada
[7] Univ British Columbia, Mary Pack Arthrit Ctr, Vancouver, BC V5Z 1M9, Canada
[8] Univ British Columbia, St Pauls Hosp, Div Rheumatol, Vancouver, BC V5Z 1M9, Canada
[9] 124 St Med Grp, Edmonton, AB, Canada
[10] JSS Med Res, St Laurent, PQ, Canada
[11] McGill Univ, St Laurent, PQ, Canada
[12] Janssen, Toronto, ON, Canada
[13] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
69
引用
收藏
页码：1480 / 1480
页数：1
相关论文
共 50 条
  • [21] Real-World Incidence and Determinants of Infection in Patients With Rheumatoid Arthritis Treated With Golimumab After a Median Follow-Up Time of 27 Months
    Bessette, Louis
    Rahman, Proton
    Kelsall, John
    Purvis, Jane
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Rachich, Meagan
    Nantel, Francois
    Asin-Milan, Odalis
    Marrache, A. Marilise
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (09) : 1121 - 1126
  • [22] IDENTIFICATION OF DISTINCT DISEASE ACTIVITY TRAJECTORIES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB OVER 12 MONTHS
    Bykerk, V. P.
    van Vollenhoven, R.
    Connell, C.
    Gruben, D.
    Fallon, L.
    Woolcott, J.
    Keystone, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 969 - 969
  • [23] First Report of Golimumab Real-World Effectiveness in Low/Moderate and High Disease Activity in Patients with Rheumatoid Arthritis
    Bensen, William
    Choquette, Denis
    Zummer, Michel
    Sholter, Dalton
    Chow, Andrew
    Dixit, Sanjay
    Sampalis, John
    Nantel, Francois
    Shawi, May
    Lehman, Allen
    Otawa, Susan
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1021 - 1021
  • [24] Real-World Effectiveness Of Infliximab In The Treatment Of Psoriatic Arthritis Over 12 Months: The Canadian Experience
    Rahman, Proton
    Khraishi, Majed M.
    Bensen, William
    Kelsall, John T.
    Hanna, Brian D.
    Watts, Craig
    Rampakakis, Emmanouil
    Sampalis, John S.
    Shawi, May
    Otawa, Susan M.
    Lehman, Allen J.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S660 - S660
  • [25] Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
    Santos-Moreno, Pedro
    Castillo, Paola
    Villareal, Laura
    Pineda, Carlos
    Sandoval, Hugo
    Valencia, Omaira
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2020, 12 : 249 - 256
  • [26] Real-World Effectiveness of Infliximab in the Treatment of Psoriatic Arthritis over 12 Months: The Canadian Experience
    Rahman, Proton
    Khraishi, Majed
    Bensen, William
    Sholter, Dalton
    Hanna, Brian
    Watts, Craig
    Rampakakis, Emmanouil
    Sampalis, John
    Shawi, May
    Otawa, Susan
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1010 - 1011
  • [27] Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity
    Yosuke Hattori
    Daihei Kida
    Atsushi Kaneko
    Clinical Rheumatology, 2017, 36 : 2607 - 2612
  • [28] Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity
    Hattori, Yosuke
    Kida, Daihei
    Kaneko, Atsushi
    CLINICAL RHEUMATOLOGY, 2017, 36 (11) : 2607 - 2612
  • [29] Comparison of Real-World Costs between Patients with Rheumatoid Arthritis Treated with Subcutaneously-Administered Biologics Previously Treated with Another Biologic
    Best, Jennie H.
    Juneau, Paul
    Kong, Amanda
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] COMPARISON OF REAL-WORLD COSTS BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUSLY-ADMINISTERED BIOLOGICS PREVIOUSLY TREATED WITH ANOTHER BIOLOGIC
    Best, J. H.
    Juneau, P.
    Kong, A. M.
    VALUE IN HEALTH, 2018, 21 : S194 - S194
12345